Meeting of the Bangladesh, Bhutan, India, Nepal, Sri Lanka (BBINS) Malaria drug resistance monitoring network
Overview
A meeting of the BBINS Malaria Drug Resistance Monitoring Network was convened in New Delhi, India on 15–16 October 2019. Country representatives from BBINS countries (Bangladesh, Bhutan, India, Nepal and Sri Lanka) and Maldives, country office focal points, experts and partners attended the meeting.
An update of the recommendations of the 2018 meeting, and results of recent therapeutic efficacy studies or integrated drug efficacy surveillance in these countries were presented. Updates on molecular marker Kelch 13 for tracking resistance to artemisinin and other malaria drugs, were also shared.
The countries then developed workplans and budgets for therapeutic efficacy studies monitoring in 2020–2021. Panel discussions were also held on updating malaria treatment regimens across
countries, based on evidence generated from the studies and data on molecular markers
for drug resistance.
